Search Results

Trust in the Food and Drug Administration: A National Survey Study.

• Authors : Feldman, William B.; Rand, Leah Z.; Carpenter, Daniel

Subjects: TRUST; ODDS ratio; LOGISTIC regression analysisUNITED States. Food & Drug Administration

• Source: Clinical Pharmacology & Therapeutics; Aug2024, Vol. 116 Issue 2, p408-414, 7p

Record details

Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA.

• Authors : Van de Wiele, Victor L.; Kesselheim, Aaron S.; Gleeson, Deborah

Subjects: DRUGS; DRUG prices; GENERIC drugsFRANCE; AUSTRALIA

• Source: Pharmaceutical Medicine; Jul2024, Vol. 38 Issue 4, p303-310, 8p

Record details

Patent Portfolios Protecting 10 Top-Selling Prescription Drugs.

• Authors : Horrow, Caroline; Gabriele, Sarah M.E.; Tu, S. Sean

• Source: JAMA Internal Medicine; Jul2024, Vol. 184 Issue 7, p810-817, 8p

Record details

Federal Trade Commission Actions on Prescription Drugs, 2000-2022.

• Authors : Daval, C. Joseph Ross; Egilman, Alexander C.; Sarpatwari, Ameet

Subjects: LEGAL documents; DRUGS; PHARMACEUTICAL industryUNITED States. Federal Trade Commission. Bureau of Consumer Protection

• Source: JAMA: Journal of the American Medical Association; 6/18/2024, Vol. 331 Issue 23, p2029-2036, 8p

Record details

How Do Risk Evaluation and Mitigation Strategies Impact Clinical Practice? A National Survey of Physicians.

• Authors : Sarpatwari, Ameet; Lu, Zhigang; Russo, Massimiliano

Subjects: GAMMA-hydroxybutyrate; PHYSICIANS; RISK assessment

• Source: Clinical Pharmacology & Therapeutics; Jun2024, Vol. 115 Issue 6, p1293-1303, 11p

Record details

Medicare Negotiation's Drug Reformulation Problem.

• Authors : Vogel, Matthew; Rome, Benjamin N.; Kesselheim, Aaron S.

Subjects: MEDICARE; NEGOTIATION; PRICES

• Source: Annals of Internal Medicine; Jun2024, Vol. 177 Issue 6, p817-819, 4p

Record details

Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label.

• Authors : Egilman, Alexander C.; Kesselheim, Aaron S.; Sarpatwari, Ameet

Subjects: MEDICARE Part D; GENERIC drugs; DRUG labeling

• Source: Annals of Internal Medicine; Jun2024, Vol. 177 Issue 6, p833-835, 11p

Record details

Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000–2020.

• Authors : Mahesri, Mufaddal; Sarpatwari, Ameet; Huybrechts, Krista F.

• Source: Drug Safety; Sep2024, Vol. 47 Issue 9, p909-919, 11p

Record details

Commercial markups on pediatric oncology drugs at 340B pediatric hospitals.

• Authors : Liu, Ian T. T.; Wang, Junyi; Sarpatwari, Ameet

• Source: Pediatric Blood & Cancer; Sep2024, Vol. 71 Issue 9, p1-4, 4p

Record details

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval.

• Authors : Liu, Ian T. T.; Kesselheim, Aaron S.; Cliff, Edward R. Scheffer

• Source: JAMA: Journal of the American Medical Association; 5/7/2024, Vol. 331 Issue 17, p1471-1479, 9p

Record details